Viewing Study NCT01532232


Ignite Creation Date: 2025-12-24 @ 9:25 PM
Ignite Modification Date: 2026-03-11 @ 12:46 PM
Study NCT ID: NCT01532232
Status: TERMINATED
Last Update Posted: 2015-12-23
First Post: 2012-02-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tobacco Dependence in Breast Cancer Patients Trial of Varenicline (Chantix)
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 11-136
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View